News and Updates

New research uncovers systemic barriers to pediatric cancer trial participation, urging for more equitable, inclusive, and accessible research strategies.

Are pharmaceutical giants suppressing peptide data? Discover the truth behind clinical research, patent limitations, and the risks of unregulated supplements.

The WHO advocates for new Ervebo vaccine clinical trials in DR Congo to strengthen Ebola defense, improve immunization strategies, and enhance public health.

The recent IND clearance for circular RNA CAR-T therapy is disrupting cell therapy trial standards. Discover how this innovation is reshaping oncology.

The FDA has cleared the IND for RXIM002, a novel circular RNA CAR-T therapy for ITP. Discover how this breakthrough could redefine treatment for the disorder.

Indian pharma records 12% revenue growth in July despite sluggish unit sales. Discover the factors driving this price-led market shift in our latest report.

The WHO recommends the Ervebo vaccine for new clinical trials to combat Ebola. Learn how this move aims to improve outbreak response and vaccine efficacy.

Despite $8.9 billion in AI drug discovery investments, zero drugs have reached FDA approval. We analyze if the AI-driven biotech hype is nearing a reset.

The FDA has authorized CLiK Extra to protect livestock from New World screwworm. Learn how this new treatment improves parasite control for animals.

Maharashtra FDA has revoked a Pune-based pharma firm's license following the discovery of contaminated medicines and severe Good Manufacturing Practices lapses.